NEUROMODULATIONSVORRICHTUNG
Patent europeic · EP4052756 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP4052756
- Numer da la dumonda
- EP22169569
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 18-08-2016
- Publitgà
- 07-09-2022
- Concedì
- 15-05-2024
- Stritgà
- 25-03-2025
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- A61N 1/36 (2006.01)
- Prioritad
- US 201562208057 P 21.08.2015
- Derivà da
- EP16760189
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 26-03-2025
Midada
Published in Swissreg on 26.03.2025
- 25-03-2025
Stritgà, taxa betg pajada
- Status of protective title
- Active → Cancelled
- Cancellation date
- 25.03.2025
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 25.03.2025
- 29-05-2024
Owner
- Owner
- Galvani Bioelectronics Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → Galvani Bioelectronics Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom
Published in Swissreg on 29.05.2024
- 15-05-2024
Concedì
Published in Swissreg on 15.05.2024
Partidas
Possessur
Inventur
CARR, Michael, John
King of Prussia, 19406-0939, US
KWONG, Kevin, K.
King of Prussia, 19406, US
HUNSBERGER, Gerald, E.
King of Prussia, 19406, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.